Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Avery Dennison, 3M Settle Patent And Antitrust Litigation - Quick Facts

RELATED NEWS
Trade AVY now with 

Avery Dennison Corp. (AVY: Quote) announced the settlement of its patent and antitrust litigation with 3M company. Avery said the company will continue to sell its OmniCube products worldwide.

The litigation began when 3M alleged that Avery Dennison infringed its patents and sought a preliminary injunction to prevent Avery from selling OmniCube, a Type XI sheeting product used to increase nighttime visibility of road signs and other highway and transportation products. The court denied 3M's request, and after Avery Dennison brought claims of its own for patent infringement and antitrust violations, the companies agreed to dismiss all three pending cases.

Click here to receive FREE breaking news email alerts for Avery Dennison Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
German consumer climate is set to improve slightly in November, ending the downward trend, as income expectations among households strengthened on the back of the strong labor market situation, survey data revealed Friday.The forward-looking consumer confidence index rose slightly to 8.5 in November from 8.4 in October. Software giant Microsoft Corp. said Thursday after the markets closed that its first quarter profit fell 13% from last year, hurt mainly by integration and restructuring costs even as revenue surged 25% thanks to strong sales of its gadgets and cloud-based products. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. After turning lower over the course of the previous session, stocks showed a substantial move back to the upside during trading on Thursday. The gains more than offset yesterday's loss, extending the recovery from the recent sell-off.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.